Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy (For Part A)”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Early research (Phase 1)Not Yet RecruitingNCT07314346
What this trial is testing

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Who this might be right for
Healthy Volunteer Study
Atea Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02629692
What this trial is testing

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Who this might be right for
Healthy (For Part A)Chronic Myeloid Leukemia (for Part B and C)
Sun Pharma Advanced Research Company Limited 122
Early research (Phase 1)Study completedNCT02186002
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACT-451840 in Healthy Subjects (Part A)

Who this might be right for
Healthy
Idorsia Pharmaceuticals Ltd. 40
Not applicableStudy completedNCT05619276
What this trial is testing

Acute Intervention to Assess the Impact of Practical Strategies for Healthy Eating

Who this might be right for
Overweight and ObesityHealthy Diet
Clinica Universidad de Navarra, Universidad de Navarra 40
Early research (Phase 1)Study completedNCT05262751
What this trial is testing

A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib

Who this might be right for
Healthy
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Study completedNCT03535168
What this trial is testing

Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients

Who this might be right for
Cough
Bayer 59
Early research (Phase 1)Study completedNCT04769869
What this trial is testing

A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma

Who this might be right for
Asthma
AstraZeneca 110
Early research (Phase 1)Study completedNCT02169583
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Who this might be right for
Infections, Respiratory Tract
GlaxoSmithKline 24
Early research (Phase 1)Ended earlyNCT06612255
What this trial is testing

A Study Comparing the Bioavailability of a Taste-masked Delafloxacin Powder for Oral Suspension With the Delafloxacin Tablet in Healthy Adults

Who this might be right for
Healthy
Melinta Therapeutics, Inc. 16
Early research (Phase 1)UnknownNCT05862623
What this trial is testing

Single and Multiple Ascending Dose Study of AER-01

Who this might be right for
COPD
Aer Therapeutics 72
Early research (Phase 1)Study completedNCT04564040
What this trial is testing

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

Who this might be right for
Mantle Cell LymphomaCOVID-19
AstraZeneca 20
Early research (Phase 1)Study completedNCT02337283
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening)

Who this might be right for
Healthy
Boehringer Ingelheim 96
Early research (Phase 1)Looking for participantsNCT05802264
What this trial is testing

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Cystetic Medicines, Inc. 108
Early research (Phase 1)Looking for participantsNCT06154837
What this trial is testing

GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 130
Testing effectiveness (Phase 2)Study completedNCT02598388
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 2-dose Heterologous Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 578
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Early research (Phase 1)WithdrawnNCT00908414
What this trial is testing

PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354.

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland
Early research (Phase 1)Study completedNCT01036061
What this trial is testing

GSK618334 Repeat Dose Study

Who this might be right for
Substance Dependence
GlaxoSmithKline 46
Early research (Phase 1)Study completedNCT06168318
What this trial is testing

Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants

Who this might be right for
HIV Infections
ViiV Healthcare 46
Early research (Phase 1)Ended earlyNCT01702350
What this trial is testing

A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study

Who this might be right for
Community-acquired Infection
GlaxoSmithKline 24
Load More Results